CHARNELE MATHIES: Open Payments
NPI 1073983771 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 51 payments from 7 companies in 2025. Trend: 2023 $1,345 · 2024 $1,253 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 24 | $533 |
| ViiV Healthcare Company | 14 | $267 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Antares Pharma, Inc. | 4 | $66 |
| ABBVIE INC. | 3 | $64 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| Exact Sciences Corporation | 2 | $41 |
Products named: VOQUEZNA, APRETUDE, XYOSTED, MAVYRET, RUKOBIA, CABENUVA, PIFELTRO, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
